The origin of GnRH-1 cells and olfactory ensheathing cells has been controversial. Genetic Cre-lox lineage tracing of the neural crest (NC) versus ectodermal contribution to the developing nasal placode was performed using two complementary mouse models, the NC-specific Wnt1Cre mouse line and an ectodermal-specific Crect mouse line. Using these lines we prove that the NC give rise to the olfactory ensheathing cells and subpopulations of GnRH-1 neurons, olfactory and vomeronasal cells. These data demonstrate that Schwann cells and olfactory ensheathing cells share a common developmental origin. Furthermore, the results indicate that certain conditions that impact olfaction and sexual development, such as Kallmann syndrome, may be in part neurocristopathies.
Introduction
Clarifying the developmental lineage of specific cell populations is fundamental to understanding syndromic diseases and to unravel the molecular etiology and relationship between various phenotypic outcomes. The nasal placodes are defined as ectodermally derived tissue thickenings that arise from the anterior end of the neural plate. Starting from embryonic day 10.5 (E10.5) in mouse, the nasal placodes invaginate and give rise to cell types including GnRH-1 neurons that migrate to the brain, olfactory sensory neurons (OSNs) that project to the brain (Wray et al., 1989) and olfactory ensheathing cells (OECs) that provide essential growth and guidance for OSN axons .
GnRH-1 neurons are a population of cells with a key role in sexual development and behavior in vertebrates (Boehm et al., 2005; Wray, 2010) . GnRH-1 neurons migrate from the nose to the brain on olfactory axons. Their migration is dependent on correct development of the olfactory sensory system (Wray et al., 1989) . Developmental pathologies affecting functional GnRH-1 expression, signaling, neuronal development, or migration translate into various forms of hypogonadism, with lack or delay of pubertal onset associated with complex syndromic reproductive dysfunctions (Chan et al., 2009; Trarbach et al., 2009; Wray, 2010) . In humans, the pathology associated with defects in olfactory system development and impaired migration of GnRH-1 neurons is called Kallmann syndrome (Wray, 2010) and is characterized by anosmia (lack of smell) and lack of pubertal onset (Sykiotis et al., 2010) . The Kallmann phenotype can be associated with other syndromic diseases such as CHARGE syndrome (Ogata et al., 2006) and can display neural crest (NC)-associated defects involving craniofacial dysmorphisms, cleft palate, dental agenesis, synkinesis, lack of mirror movements, deafness, ocular albinism, cerebellar defects, and dementia (Krams et al., 1997; Molsted et al., 1997; Ueno et al., 2004; Hou, 2005; Zenaty et al., 2006; Bhagavath and Layman, 2007) . However, localization and lineage of GnRH-1 progenitors is still unclear. Placodal, nonplacodal ectodermal, and NC origins have all been proposed for these cells (elAmraoui and Dubois, 1993; Whitlock et al., 2003; Merlo et al., 2007; Metz and Wray, 2010) .
The NC is an embryonic cell type unique to vertebrates that arises at the junction between the neural tube and epidermis. At early developmental stages, pluripotent NC cells migrate throughout the organism and give rise to many derivates including neurons and glia of the peripheral nervous system, bone and cartilage of the skull, and melanocytes (Bronner-Fraser, 1995) . To explore NC and ectodermal contribution to the development of the olfactory and GnRH-1 systems, genetic Cre-lox lineage tracing of NC derivatives and ectodermal derivatives was performed using the NC-specific Wnt1Cre mouse line and an ectodermal-specific Crect mouse line. By using two complementary mouse models, we demonstrate the NC origin of the OECs and an NC contribution to subsets of GnRH-1 neurons and cells of the olfactory epithelium (OE) and vomeronasal organ (VNO). These findings offer a new scenario for the development of GnRH-1 neurons and the olfactory system, and provide a link between NC defects and anosmia associated with hypogonadic syndromes.
Immunolabeling
Primary antibodies. All antibodies used were polyclonal unless otherwise indicated: GnRH-1 (SW-1, 1:3000) (Wray et al., 1988) , rabbit (Rb) antiperipherin (peripheral intermediate filament marker; 1:2000; Millipore Bioscience Research Reagents), mouse monoclonal biotinylated antiHuC-D (1:100; Invitrogen), goat anti-Sox2 (1:800; Santa Cruz Biotechnology), Rb anti-Sox2 (1:500; Millipore Bioscience Research Reagents), mouse monoclonal anti-Tubulin III (Tuj-1, 1:700; Sigma-Aldrich), goat anti-olfactory marker protein (OMP) (1:5000) (Keller and Margolis, 1975) , chicken anti-green fluorescent protein (GFP)/yellow fluorescent protein (YFP) (1:1000; Abcam), Rb anti-GFP/YFP (1:20,000; Invitrogen; used in double-labeling experiments involving primary antibodies made in goat), Rb anti-PAX6 (1:400; Millipore Bioscience Research Reagents), mouse monoclonal anti-PAX7 [supernatant 1:3; Developmental Studies Hybridoma Bank (DSHB), University of Iowa], mouse monoclonal antiAp-2␣ (3B5 supernatant 1:3; DSHB), Rb anti-PAX7 (1:450; Santa Cruz Biotechnology), goat anti-Sox10 (1:400, Santa Cruz Biotechnology), mouse monoclonal anti-Sus4 (1:200; gift of J. Schwob, Tufts University School of Medicine, Boston, MA), Rb anti-GFAP (1:5; Millipore Bioscience Research Reagents), Rb anti-p75 (1:5000; Millipore Bioscience Research Reagents), Rb anti-brain lipid binding protein (BLBP) (1:1000; Millipore Bioscience Research Reagents), Rb anti p-Histone-3 (1:300; Millipore), and mouse monoclonal anti-Cre (1:200; Sigma). For the antigens Sox2, PAX6, PAX7, p-Histone-3, and AP-2␣, microwave antigen retrieval treatment in citrate buffer was performed before immunostaining (Forni et al., 2006) ; for Sox10, a 5-10 min 100% methanol pretreatment was performed.
Chromogen-based reactions. Sections were washed in PBS, blocked in 10% normal horse or goat serum (depending on experimental needs) and 0.3% Triton X-100 and then washed in PBS. After incubations with primary antibody (1 h at room temperature or 4°C overnight), the following biotinylated secondary antibodies were used: goat anti-rabbit (GAR-Bt; Vector Laboratories), goat anti-mouse (GAM-Bt; Millipore Bioscience Research Reagents), and donkey anti-chicken (DAC-Bt; Jackson ImmunoResearch). After PBS washes, the tissues were processed using a standard avidin-biotin-horseradish peroxidase/3Ј, standard 3-diaminobenzidine (DAB) protocol or nickel-intensified DAB (Kramer et al., 2000) .
Immunofluorescence. Depending on the primary antibody used, sections or explants were incubated for 1 h with the following secondary antibodies: goat anti-rabbit (GAR) 488 (1:1000), GAR 555 (1:1000), donkey anti-rabbit (DAR) 488 (1:1000), donkey anti-goat 568 (1:1000), goat anti-mouse 488 (1:1000), goat anti-mouse 555 (1:1000), avidin cy3 (1:1000), goat antichicken 488 (1:1000) (all from Invitrogen), and daylight fragment antigenbinding DAR 549 and 488 (1:1000; Jackson ImmunoResearch). Sections were counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI; 1:3000/ PBS; Sigma-Aldrich), rinsed in deionized water, and coverslipped with Fluoro Gel (Electron Microscopy Service). Confocal pictures were taken on a spinning disk confocal system (CSU10; Yocogawa) mounted on an Eclipse TSE200 microscope (Nikon) using an EMCCD ImageM digital camera (Hamamatzu) with I-Vision software (Biovision). Nonconfocal fluorescent pictures were taken on a Nikon Eclipse E800 with a Retiga SRV camera using QCapture software (QImaging). Images were further analyzed using NIH ImageJ software (W. Rasband, NIH, Bethesda, MD).
Cre expression. Serial sections from Wnt1Cre/RYFP embryos immunostained for Cre and YFP as described above were analyzed at E8.5 (N ϭ 5; two or three sections per animal), E9.5 (N ϭ 2; five sections per animal), E10.5 (N ϭ 3; seven sections per animal), and E11.5 (N ϭ 2; seven sections per animal).
X-Gal staining
For X-Gal staining, sections were rinsed in PBS (10 min) and then incubated overnight at 37°C in a solution of 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 , 0.1% Tween 20, 0.1% 5-bromo-4-chloro-3-indolyl-␤-D-galactoside/N,N-dimethylformamide (Prunotto et al., 2004) . Sections from RLacZ animals negative for Cre were used as negative controls. After enzymatic reaction slides were either counterstained with Eosin B (Sigma-Aldrich) following the standard procedure and coverslipped or washed and immunostained as described above.
Cell counts
Labeled GnRH-1 cells in vivo. The number of GnRH-1ϩ/␤Galϩ cells were counted at 20ϫ on a brightfield microscope after X-Gal enzymatic reaction and GnRH-1 immunolabeling. Counts were performed on at least two series per animal. The number of GnRH-1ϩ/␤Galϩ cells and the number of total GnRH-1 cells were calculated for each animal as the average of the counted cells per series multiplied by the number of series cut per animal. At least three animals per group were counted, and the mean number of GnRH-1ϩ/␤Galϩ cells and the total number of GnRH-1 cells were obtained. The data are presented as the percentage of GnRH-1ϩ/␤Galϩ cells.
YFP/Hu cells. Wnt1Cre/RYFP E10.5 embryonic sections were immunolabeled for Hu and YFP; Huϩ/YFPϩ cells and total YFPϩ cells in the olfactory pit were counted on four coronal sections in one series for each embryo (N ϭ 3). Mean values were calculated for each animal. The data are presented as the percentage of Huϩ/YFPϩ cells over total YFP cells counted.
Asymmetry of recombinant cells. Quantification of cells positive for the Wnt1 lineage on the left versus the right side was performed on coronal sections containing (1) the olfactory pit region at E10.5-E11.5 (N ϭ 3; 6 -12 sections per animal), (2) the OE at E16.5-P0 (N ϭ 5; 6 -27 sections per animal), and (3) the VNO at E16.5-P6 (N ϭ 4; 4 -36 sections per animal). Sections were examined at 25ϫ, and cells within the region of interest were counted. The percentage of cells on left versus the right were calculated for each animal based on total number of labeled cells in the region, and a mean percentage was obtained for each group.
Comparison of Wnt1Cre and Crect recombination. To compare recombination numbers between Wnt1Cre and Crect animals, cells either positive or negative (respectively) for Cre recombination were counted in five coronal sections per animal, stained for YFP, Hu, and DAPI from P0 -P6 mice (N ϭ 3 per group; 40ϫ). Because of the consistent lower recombination observed on the left side of Wnt1Cre animals, all counts were performed on the right side of the VNO. To control for differences in cell density (attributable to age and/or strain), cell counts based on DAPI nuclear staining were performed on two sections per animal from a P5 Crect/RYFP mouse, a P6 Wnt1Cre/RYFP mouse, and P0 Wnt1Cre/ RYFP mouse. DAPI-positive nuclei were counted in two regions per section (50 m 2 each; 20ϫ) of the sensory VNO. Cell density was then used to calculate the total number of cells per area counted for each animal. Positive (Wnt1Cre) and negative (Crect) cells are reported as the number of cells counted per 3225 VNO cells (smallest area examined of the six mice).
GnRH-1 and OEC quantification in Wnt1Cre/RYFP nasal explants. Counts were performed on 40ϫ or 60ϫ confocal digital images obtained .5 showed ␤-gal expression (blue) throughout the nasal ectomesenchyma (NM) and in some cells in the olfactory pit (OP; arrowheads). From E11 to E11.5 (C, D), ␤-galϩ cells were detected spanning between the dorsal and ventral rim of the invaginating pit (C, between black arrowheads) at the level of the putative RE, VNO, and part of the developing OE. E-G, Near the rim of the invaginating pit, AP-2␣ϩ and PAX7ϩ cells overlap in regions marked by Wnt1Cre lineage tracing expression (arrowheads; E11.5 is shown). E, AP-2␣ was expressed in the superficial ectoderm (Ect), rostral part of the dorsal and ventral (asterisk) portion of the RE. F, PAX7ϩ cells were found in the NM, at the dorsal rim of the invaginating pit, and in the rostral part of the dorsal portion of the RE, whereas the majority of the cells in the ventral RE (asterisk) where negative for PAX7 expression. No immunodetectable PAX7 was found in the OE and VNO, demarcated by the neuronal marker Hu. G, Region from a Wnt1Cre/RYFP embryonic section, comparable to area boxed in F, immunostained against YFP. Recombination was found in some cells along the Ect, at the dorsal rim of the OP, along the RE, and spanning between dorsal and ventral (asterisk) rim of the RE. H, Double immunostaining for PAX7 and AP-2␣ϩ identified PAX7 expression in subsets of AP-2␣ϩ cells (arrowheads; E11.5 is shown). Double-labeled cells were detected along the superficial Ect, lining the invaginating pit, and spanning from the dorsal to the ventral ( from Wnt1Cre/RYFP nasal explants immunofluorescently stained for YFP/GnRH-1 (N ϭ 3) or YFP/p75 (N ϭ 3).
Recombination in Bowman's gland. Cells were analyzed at 40ϫ on five section per animal (P0 -P6; Crect/RYFP, N ϭ 3; Wnt1Cre/RYFP, N ϭ 3). Bowman's glands were identified by Sox2 immunostaining (Guo et al., 2010) on YFP/Sox2-immunolabeled sections. The percentage of cells positive for recombination per animal was determined and the mean percentage was calculated per group.
Results

Fate-mapping identification of neural-crest-derived cells in the olfactory pit
To investigate, whether there is an NC contribution to olfactory pit development and to test the lineage of GnRH-1 neurons and OECs in mice, genetic cell fate tracing was performed by crossing the NC-specific Wnt1Cre line (Danielian et al., 1998) with Rosa reporter mouse lines (Soriano, 1999; Srinivas et al., 2001) . Wnt1 encodes a glycoprotein that is transiently expressed in premigratory NC (Echelard et al., 1994; Nichols and Bruce, 2006) . In Wnt1Cre/RLacZ or Wnt1Cre/RYFP double mutants, irreversible expression of the tracer occurs after Cre-mediated recombination. This allows tracing of cells originating from NC after recombination (Nagoshi et al., 2008) .
From E9.5 to E10.5, Wnt1Cre recombination was found in the developing facial mesenchyma and in a subset of cells distributed along the invaginating olfactory pit and the ectoderm lining the nasal placode ( Fig. 1 A, B , M, N ). At E11, cells positive for Wnt1Cre recombination were detected in the presumptive respiratory epithelium (RE), the presumptive OE (Fig. 1C) , and where the dorsal and ventral rims of the invaginating nasal pit fuse (Fig.  1C , between black arrows). Wnt1Cre positive cells were also located in the superficial ectoderm, adjacent to the rim of the olfactory pit. These cells were distributed in a stream that often was contiguous with positive cells in the developing RE (Fig.  1C,G) . From E11 to E11.5, the number of cells positive for Wnt1Cre-mediated recombination increased in the RE, VNO, and OE (Fig. 1C,D) .
Cells positive for Wnt1Cre tracing express PAX7 and AP-2␣
AP-2␣ and PAX7 are transcription factors expressed by NC and are required for craniofacial patterning (Mansouri et al., 1996; Brewer et al., 2004) . Notably, AP-2␣ is expressed by epithelial cells able to produce keratin and is expressed in the developing RE (Leask et al., 1991; Kramer et al., 2000b) . However, both AP-2␣ and PAX7 can also be expressed by embryonic ectoderm (Leask et al., 1991; Lacosta et al., 2005; Basch et al., 2006) . At E11.5, immunolabeling for AP-2␣ marked the ectoderm, craniofacial mesenchyma, NC-derived nasal ectomesenchyma (LaMantia et al., 2000) , and the majority of ectodermal cells along the putative RE (Fig. 1 E) . Immunostaining for PAX7 (Fig. 1 F) also showed expression in cells located in the NC-derived nasal ectomesenchyma as well as in cells at the rim of the invaginating nasal pit and along the putative RE, the same areas where cells positive for AP-2␣ (Fig. 1 E) and Wnt1Cre fate mapping were identified (Fig. 1C,G) . No PAX7 immunoreactivity was detected in the OE or VNO, delineated by staining for the early pan neuronal marker HuC/D (Fig. 1 F) (Forni et al., 2011) . Double immunostaining for PAX7 and AP-2␣ revealed coexpression in a subset of AP-2␣ positive cells, distributed along the ectoderm lining the nasal cavity into the RE (Fig. 1 H) .
To determine whether the cells positive for NC fate mapping also expressed AP-2␣ and PAX7, immunostaining on E11.5 sections of Wnt1Cre/RYFP mice was performed. Cells positive for Wnt1Cre-mediated recombination together with AP-2␣ ( Fig.  1 I, J ) and PAX7 ( K, L) were found along the superficial ectoderm lining the pit ( I, K ), in the dorsal rim of the nasal pit ( J, L), and distributed along the ventral portion of the putative RE (data not shown). These experiments document the expression of two commonly used NC markers in cells positive for Wnt1Cre fate tracing in the developing nasal placode.
A subpopulation of GnRH-1 neurons is positive for NC tracing PAX6 is a transcription factor fundamental for development of placodal structures and GnRH-1 neurons (Dellovade et al., 1998) . Expression studies indicate that Pax6 is expressed in the nasal ectoderm (Purcell et al., 2005; Bhattacharyya and Bronner-Fraser, 2008) . Immunolabeling for AP-2␣ and PAX6 at E11.5 revealed AP-2␣ expression in PAX6-negative areas of the developing RE and PAX6 expression in AP-2␣-negative areas of the developing OE (Fig. 2 A) . However, within the developing VNO, AP-2␣-positive cells were intermingled with PAX6-positive cells, but coexpression was not detected. (Fig. 2B,C) . These data suggest that AP-2␣ and PAX6 define distinct progenitor cells mixed within the developing nasal placode.
At E11.5, the first GnRH-1-expressing cells can be immunodetected in the ventromedial portion of the developing VNO, an area where AP-2␣ and Wnt1Cre recombination is detected (Fig. 2D-F) . Double labeling for AP-2␣ and GnRH-1 highlighted AP-2␣ expression in early GnRH-1 neurons in both the putative RE and in the ventral part of the VNO (Fig. 2G) . Immunostaining for PAX6 and GnRH-1 showed GnRH-1 neurons did not express PAX6 (Fig. 2 H) . These data suggest an independent lineage for GnRH-1 neurons and VNO sensory neurons (pheromone receptors). Cells positive for AP-2␣ and Wnt1Cre recombination were also detected at E11.5 in the putative RE (Fig. 2 I) and VNO (data not shown). GnRH-1 immunostaining on E11.5 sections of Wnt1Cre/RLacZ or Wnt1Cre/RYFP mice highlighted Wnt1Cre recombination in some GnRH-1 neurons in both nasal (Fig. 2 J, K ) and brain ( Fig.  2 L-N ) regions. Cell counts on Wnt1Cre/RLacZ mice sections from E16.5 to P0, time points at which GnRH-1 neuronal migration to the brain has been completed (Forni et al., 2011) , showed Wnt1Cre-mediated recombination in 37 Ϯ 9% of the total GnRH-1 neuronal population (N ϭ 6).
Wnt1Cre lineage in olfactory tissues
During early development of the olfactory system, expression of both AP-2␣ and PAX7 was found in cells positive for Wnt1Cre recombination. Immunolabeling sections of E10.5 Wnt1Cre/ RYFP embryos with HuC/D revealed that a small percentage of cells positive for recombination in the developing pit were newly formed neurons (4%; N ϭ 4). Later stages were examined to understand the final fate of the identified precursors.
Wnt1Cre recombination was found in cells in OE, RE, and VNO (Fig. 3A) . In all analyzed animals, higher penetrance of recombination was noticed in the right OE and VNO. Quantification of cells positive for the recombination was performed at E10.5-E11.5 in the olfactory pit and at E16.5-P6 in the OE and VNO on both sides. Although the total number of labeled cells varied, the number of recombined cells was always greater on the right side of the animal independent of age. In fact, all regions examined had ϳ65% of labeled cells on the right side and ϳ35% on the left (E10.5-E11.5, N ϭ 3, olfactory pit, 63 Ϯ 7.5% right; E16.5-P6, N ϭ 3, OE, 68 Ϯ 3% right; VNO, 65 Ϯ 3.4% right). These data suggest lateral differences in the levels of Wnt1Cre activation with respect to the timing of migration (Baker et al., 1997) of these NC cells into the placode.
Identification of the cell types that were positive for Wnt1Cre recombination in the OE, RE, and VNO was performed on late staged embryos and perinatal and adult animals. The neuronalspecific antigen Tuj-1 labeled neurons positive for Wnt1Cre recombination in the OE (Fig. 3B) . Cre recombination was also found in cells negative for Tuj-1 in both the OE as well as the RE (Fig. 3B) . Immunolabeling with OMP confirmed that subpopu- lations of olfactory neurons arise via the Wnt1Cre lineage (Fig.  3C) . Next, the cell lineage of sustentacular cells, which act as support cells within the OE, was examined. Sox2 is expressed by both sustentacular cells and by globose olfactory stem cells (Guo et al., 2010) , whereas SUS4 marks sustentacular cells (Goldstein and Schwob, 1996; Goldstein et al., 1997) . Immunolabeling for Sox2 (Fig. 3D ) and SUS4 ( E) highlighted Wnt1Cre recombination in subpopulations of sustentacular cells. Sox2-expressing cells, positive for Wnt1Cre tracing but negative for SUS4 staining (data not shown) were also detected in the nonneuronal RE (Fig.  3F ) . A spatial correlation was observed in the distribution of olfactory neurons and sustentacular cells positive for recombination suggestive of a common "clonal" origin of these cells from Wnt1Cre-lineage-derived progenitors (Fig. 3 D, G,H ) . At postnatal stages, Sox2 and PAX6 are expressed by Bowman's glands and sustentacular and globose cells (Guo et al., 2010) . Staining for PAX6 and Sox2 confirmed the presence of globose cells positive for Wnt1Cre tracing intermingled with globose cells negative for the recombination in the same areas where olfactory neurons and sustentacular cells positive for Wnt1Cre tracing were found (Fig. 3G-I) . No recombination was detected in Bowman's glands. Wnt1Cre cell fate tracing also highlighted the presence of positive cells in the VNO (Fig. 3J) . In this region, subpopulations of sensory neurons (OMP positive) positive for Wnt1Cre tracing (Fig. 3K) were found together with Sox2 positive sustentacular cells (Fig. 3L) . In the nonsensory epithelium, recombination was occasionally found in nonsensory ciliate cells (Fig. 3M) .
Olfactory ensheathing cells are positive for Wnt1Cre tracing
Analyzing Wnt1Cre/RLacZ mice, recombination was noticed around the olfactory bulbs (Fig. 4A) , in an area where olfactory axons (Fig. 4B) , surrounded by ensheathing cells (Fig. 4C) , project to the olfactory bulbs. OECs can be identified by GFAP, P75, and BLBP expression (Wewetzer et al., 2002; Murdoch et al., 2010) . Immunolabelings for p75 (Fig. 4D,E) , GFAP (Fig. 4F) , and BLBP (data not shown) confirmed Wnt1Cre recombination in OECs; no recombination was found in glia within the bulbs (Fig. 4F) . Cells positive for Wnt1Cre tracing were found surrounding peripherin positive olfactory axon bundles (Fig. 4G,H) projecting to the bulbs and proximal to the OE (Fig.  4H) . Because the OECs were positive for the NC tracing, we verified whether, as for NC derived Schwann cells of the peripheral system (Joseph et al., 2004) , Sox10 was expressed (Finzsch et al., 2010) . Sox10 immunostaining showed Sox10 expression in the OECs positive for Wnt1Cre tracing (Fig. 4I) .
To address whether the early NC cells detected within the developing placode give rise to OECs, E10.5 embryos were examined. At this stage, a migratory cell mass emerges from the olfactory pit (Miller et al., 2010) . HuC/D-positive migratory neurons (Fornaro et al., 2003) were found to be surrounded by nonneuronal Sox10-positive OEC precursors (Fig. 5A) . The majority of the migratory neurons were negative for Wnt1Cre tracing (Fig. 5B) , whereas the Sox10-positive cells surrounding the migratory neurons were positive for Wnt1Cre tracing (Fig. 5C) . No Sox10-positive cells were detected within the olfactory pit at this stage (Fig. 5C ). Cells positive for Wnt1Cre recombination were found at the apical side of the invaginating pit and spanning across the epithelium to the basal edge, the majority of which were negative for the neuronal marker Hu C/D (Fig. 5D ). Proliferative cells positive for Wnt1Cre recombination were found at the apical level of the invaginating pit, giving rise to daughter cells nearing the basal edge (Fig. 5E ). As cells positive for the recombination (YFPϩ) reached the basal edge of the developing placode, Sox10 expression was detected (Fig. 5 A, F ) . These cells surrounded the migratory neuronal mass as it moved toward the forebrain ( 5A-C). These data strongly suggest that at early stages NC cells within the placode (positive for Wnt1Cre recombination) give rise to OEC progenitors.
In vitro analysis on embryonic nasal explants (Fig. 5G) (Ichikawa and Osada, 1995; Toba et al., 2008) confirmed Sox10 expression in p75ϩ OECs (Fig. 5H,I ) and recombination in a subpopulation of GnRH-1 neurons (Fig. 5J) . Quantification of doublelabeled cells in 7 day in vitro (7DIV) explants revealed a 93 Ϯ 8% penetrance of Wnt1Cre recombination in p75ϩ OECs (N ϭ 3) and a 27 Ϯ 3% recombination in GnRH-1 neurons (N ϭ 3), similar to that observed in vivo.
Ectodermal lineage tracing labels the majority of sensory and GnRH-1 neurons, but not olfactory ensheathing cells Wnt1Cre tracing analysis, together with the expression of the NC markers AP-2␣, PAX7, and Sox10, suggested an NC origin for OECs and a potential common NC origin for subpopulations of GnRH-1 neurons and olfactory/vomeronasal cells. Previous analysis at E13.5 indicated that Wnt1 is not expressed in the developing olfactory system (Rodriguez-Gil and Greer, 2008) . To rule out ectopic Cre expression in the developing placode, immunostaining for Cre was performed on embryos at E8.5 (N ϭ 5), E9.5 (N ϭ 2), E10.5 (N ϭ 4), and E11.5 (N ϭ 2). At E8.5, cranial NC cells positive for the recombination were detected invading the interstitial space between the developing brain and the superficial ectoderm (Fig. 6A) . Because of the stability of the protein, Cre was still immunodetectable in some cells of the facial mesenchyma (Echelard et al., 1994; Forni et al., 2006) (Fig. 6 B) . Notably at this stage, some cells positive for Wnt1 Cre recombination were already detected in association with the superficial ectoderm where no Cre immunoreactivity was found (Fig. 6 B) . Analysis at E9.5, E10.5 (Fig. 6 D, E,G,H ) , and E11.5 (data not shown) did not detect ectopic Cre expression in the developing placode, where cells positive for the recombination were found. At all analyzed ages, Cre immunoreactivity was found in the dorsal neural tube (Fig. 6C, F, I ) and developing hindbrain (data not shown).
To ensure that cells positive for Wnt1Cre lineage were not derived from the ectoderm of the nasal placode, an AP-2␣-based Cre recombinase transgene was used that is specifically expressed in the early ectoderm of the head from E8.5 onward. In this animal model (Crect line), recombination occurs in all cranial placodes and ectodermally derived tissues (Harlow et al., 2011) . The utility of this transgenic line relies on the observation that discrete enhancer elements within Tcfap2a drive expression in facial ectoderm and NC-derived mesenchyme, respectively (Zhang and Williams, 2003; Harlow et al., 2011) .
Crect-mediated recombination was found in the OE and in axonal bundles projecting to the olfactory bulbs (Fig. 7 A, C, E, G) . No recombination was found in the tissue area juxtaposed to the OE and surrounding the olfactory axons where the OECs localize (Fig. 7C, E, G) . The Crect/RLacZ recombination pattern appeared complementary to that observed in Wnt1Cre/R animals ( Fig.  7 B, D, F, H ) . Indeed, in Crect/RYFP mice, immunofluorescence for Hu/peripherin and YFP showed ectodermal recombination in the majority of mature and immature olfactory neurons, detectable in both soma (Hu) and axons (peripherin). Recombination was observed in all Bowman's glands (Fig. 7E ) (see Materials and Methods) but not in the OECs (Fig. 7, compare E, F ) . Immunofluorescence for OMP and YFP verified that ectodermal recombination occurred in olfactory neurons but not in OECs (Fig. 7 , compare E, G, F, H ). These data confirm the NC origin of the OECs indicated by Wnt1Cre tracing.
To evaluate the complementary pattern of Crect recombination and Wnt1Cre recombination in more detail, the OE and VNO were further evaluated (Fig. 8, compare A, E, B, F ) . In both the OE (Fig. 8C,D) and VNO (G,H ), small subpopulations of cells negative for Crect mediated recombination were observed with similar distribution to that observed after Wnt1Cre recombination. To compare the relative number of cells negative for Crect to cells positive for Wnt1Cre tracing, samples from the VNO, which is a smaller and well defined area, were counted (N ϭ 3 mice/line). Wnt1Cre recombination was found in 7.3 Ϯ 0.7% of cells and 6.4 Ϯ 1.7% were found negative for Crect recombination (Fig. 8 K) (see Materials and Methods). GnRH-1 neurons (N ϭ 3) ( Fig. 8 I, J ) also revealed a complementary recombination with 73 Ϯ 7% of the GnRH-1 neurons in the brain positive for Crect recombination, which, together with the 37 Ϯ 9% positive for Wnt1Cre tracing, accounts for the entire GnRH-1 neuronal population.
Analysis of Crect recombination in
Discussion
The origin of GnRH-1 neurons and OECs has been a matter of debate for several decades. Both cell types are associated with the olfactory/nasal placode (Schwanzel-Fukuda and Pfaff, 1989; Wray et al., 1989; Wewetzer et al., 2002; Barnett, 2004; Murdoch et al., 2010) . During early development, the nasal placode and cranial neural crest cells share a common border, originating from ectoderm near the neural plate. Mixing of NC and olfactory placode cells has been suggested (Couly and Le Douarin, 1985; Whitlock, 2004; Schlosser, 2010) . Thus, we used both NC and ectodermal-specific Cre-lox fate tracing strategies to determine the origin of nasal placode derivates. Here we show that early multipotent cranial NC cells mingle with ectodermally derived cells in the developing nasal placode where they generate (1) unique cell types such as the OECs and (2) neurons with similar features to those of ectodermal origin (Nagoshi et al., 2008 (Nagoshi et al., , 2009 ) including a population of GnRH-1-expressing neurons.
The organization and development of the vertebrate head relies in part on contributions from two ectodermal derivatives, the cranial placodes, and the NC. Previous studies have proven an NC origin for peripheral glia and an NC contribution to ectodermally derived mesencephalic cranial placodes (D'Amico-Martel and Noden, 1983; Begbie and Graham, 2001; Barlow, 2002; Harlow et al., 2011) . The notion of an ectodermal versus NC origin of OECs and Schwann cells has puzzled the scientific community for years (Couly and Le Douarin, 1985; Wewetzer et al., 2002) . Indirect evidence has suggested a link between these two cell types based on morphology, molecular markers, and function . The OECs, (initially named olfactory Schwann cells), like Schwann cells of the peripheral nervous system, promote axonal regrowth and remyelination in the central and peripheral nervous systems (Boyd et al., 2005) . A recent study using Pax7Cre genetic tracing showed recombination in OECs, together with subpopulations of olfactory/vomeronasal neurons and sustentacular cells (Murdoch et al., 2010) . These authors suggested an NC contribution to the development of the olfactory system but could not rule out an ectodermal contribution attributable to normal expression of Pax7 during development (Basch et al., 2006) . Our experiments show that OECs are positive for Wnt1Cre tracing and negative for ectodermal-specific Crect tracing, proving an exclusive NC origin of OECs in mammals. These data explain the high level of biological and molecular similarity between OECs and Schwann cells and open a new prospective to understanding the interplay between ectoderm and NC (Begbie and Graham, 2001; Barlow, 2002; Creuzet et al., 2004; Zhu et al., 2010; Harlow et al., 2011) in normal and pathological development of the olfactory system.
Since submission of this manuscript, evidence for an NC origin of OECs has been published using neural crest and ectodermal grafts in chicken and Wnt1Cre tracing in mouse (Barraud et al., 2010) . As in our study, Barraud et al. (2010) observed Wnt1Cre recombination in OECs and identified Sox10 as a marker of OECs. However, in contrast to results reported for Wnt1Cre recombination in mouse by Barraud et al. (2010) , we observed cells positive for Wnt1Cre fate mapping in the nasal placode starting from early stages. At E10.5, maturing Sox10- positive OEC precursors, positive for Wnt1Cre tracing, formed a continuum with recombination positive cells in the placode. These data indicate that NC cells commingle with placodal ectoderm and that NC-derived progenitors in the placode give rise to cells with different fates including OECs. In addition the expression pattern of Sox10 suggests that it may play a role in OECs maturation, as described for peripheral Schwann cells (Britsch et al., 2001; Finzsch et al., 2010) .
Consistent with a neural crest contribution to the olfactory placode, quail chick graft experiments by Couly and Le Douarin (1985) demonstrated that "olfactory Schwann cells" were of placodal origin, but speculated that NC cells may be associated with the neural ridge before transplantation. This possibility, described by Couly and Le Douarin (1985) , would also explain the neural crest "contamination" in ectodermal grafts described by Barraud et al. (2010) , rather than the nonplacodal origin of the OECs. Other reports support OEC generation from progenitors within the developing olfactory epithelium. Studies on purified cells generated from olfactory epithelium showed clones that generated glial cells with an OEC phenotype (Mumm et al., 1996; Beites et al., 2005) . In addition, cultures of OECs have been obtained from dissociated olfactory epithelium from both humans and mice (Chuah and Au, 1991; Au and Roskams, 2002; Zhang et al., 2004; Savchenko et al., 2005; Lima et al., 2006; Ito et al., 2008; Richter et al., 2008) .
GnRH-1, vomeronasal, and olfactory neurons have a mixed ectodermal and NC origin Wnt1Cre recombination was found in ϳ30% of the GnRH-1 neurons. This raised the possibility of ectopic Wnt1Cre expression. No Cre expression was found in preplacodal ectoderm or in the developing placode, indicating that Cre was not ectopically expressed. Moreover quantification for Wnt1Cre recombination in GnRH-1 neurons in nasal explants was consistent with that observed in vivo. This negated a potential environmental brain effect on ectopic Wnt1Cre induction (Echelard et al., 1994) . Thus, the data point to a mixed origin of these neurons. To verify this, the ectodermal Crect mouse line was used. Crect fate map- ping indicates that ϳ70% of the GnRH-1 cells are of ectodermal origin. These findings confirm that GnRH-1 neurons are derived from two different lineages, with the majority originating from ectodermal cells and the remaining fraction of NC origin. These data are consistent with a previous report in which Dlx5 expression was found in 70% of migratory GnRH-1 neurons (Merlo et al., 2007) . In fact, heterogeneity has been described within GnRH-1 expressing neurons at both the morphological and molecular levels (Wray and Hoffman, 1986; Jasoni et al., 2005; Cottrell et al., 2006; Constantin et al., 2009; Jasoni et al., 2009; Klenke et al., 2010) . Moreover, a number of genetic mutations in mouse selectively affect only ϳ30% of the GnRH-1 neuronal population (Kramer et al., 2000a; Kruger et al., 2004; Givens et al., 2005; Tsai et al., 2005; Cogliati et al., 2007; Giacobini et al., 2007; Miller et al., 2009; Forni et al., 2011) . Reassessing some of these studies to determine whether heterogeneity is correlated with GnRH-1 cell lineage may be valuable. The GnRH-1 neurons have been hypothesized to originate from the nasal placode, NC, and RE (Wray et al., 1989; Dellovade et al., 1998; Whitlock, 2005) . This study provides an explanation for these previous contrasting hypotheses. Indeed, in mouse, GnRH-1 neurons originate from both NC and ectodermal progenitors in a region within and at the border of the RE ectoderm and the developing VNO.
A comparison of the results obtained using Wnt1Cre and Crect revealed complementary patterns of staining in the VNO and olfactory epithelia. Cell counts on VNO samples confirmed that the cells negative for ectodermal recombination were similar in number to those positive for Wnt1Cre tracing. These findings suggest that subpopulations of cells in the olfactory and VNO epithelia might share common NC origin with the OECs, distinct from the surrounding populations of ectodermal origin. As in the GnRH-1 neuronal population, heterogeneity has also been described in olfactory and vomeronasal neurons and globose/basal cells (Fulle et al., 1995; Giannetti and LeJeune, 1996; Goldstein and Schwob, 1996; Juilfs et al., 1997; Gibson and Garbers, 2000; Manglapus et al., 2004; Carson et al., 2006; Roskams, 2007, 2008; Murdoch et al., 2010) . Moreover, the presence of NC-derived progenitors in the olfactory epithelium (Fernandes et al., 2004; Biernaskie et al., 2006) is supported by the identification of multipotent cells able to generate neurons, glia, and myofibroblasts (Fernandes et al., 2008) .
Unraveling the NC origin of the OECs and NC contribution to the GnRH-1 neurons and vomeronasal/olfactory sensory epithelium is a crucial step for understanding the relation among syndromic developmental defects. Our studies provide an important framework to interpret the genetic causes of sexual pathologies associated with anosmia and NC craniofacial and sensory defects, and indicate that certain conditions impacting olfaction and sexual development, such as Kallmann syndrome, may be in part neurocristopathies. Further characterization of the molecular contribution of the NC to early nasal placode development, as well as the contribution of NC and ectodermal subpopulations to reproductive and olfactory system function, will provide insight into vertebrate development and physiology.
